Lasa Supergenerics Limited — Others, 27-03-2025: Trading Window

LASA Supergenerics Limited has announced a board meeting on April 1, 2025, to close the trading window for its equity shares. This closure affects designated employees and their immediate relatives, lasting until 48 hours after the declaration of the financial results for the quarter and year ended March 31, 2025. The timing indicates a strategic move to safeguard against insider trading ahead of key financial disclosures. This could suggest a focus on maintaining governance and transparency, which may foster a positive outlook among investors anticipating the results.